Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Merck
McKesson
Argus Health
Federal Trade Commission
Baxter
Mallinckrodt
QuintilesIMS
Express Scripts

Generated: December 17, 2018

DrugPatentWatch Database Preview

Sevelamer hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for sevelamer hydrochloride and what is the scope of sevelamer hydrochloride patent protection?

Sevelamer hydrochloride is the generic ingredient in one branded drug marketed by Genzyme and is included in two NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Sevelamer hydrochloride has forty-one patent family members in thirty-one countries.

There are thirty-two drug master file entries for sevelamer hydrochloride. Five suppliers are listed for this compound.

Pharmacology for sevelamer hydrochloride
Synonyms for sevelamer hydrochloride
(C3H7N)m.(C3H5ClO)n.(HCl)x
152751-57-0
182683-00-7
198343-01-0
2-(chloromethyl)oxirane; prop-2-en-1-amine; hydrochloride
2-Propen-1-amine polymer with (chloromethyl)oxirane hydrochloride
2-Propen-1-amine, hydrochloride, polymer with (chloromethyl)oxirane
2-propen-1-amine,hydrochloride,polymer with (chloromethyl)oxirane
AB01568265_01
AC-2089
AC1L4LHX
AC1Q3UBQ
AKOS025149504
Allylamine hydrochloride - epichlorhydrin copolymer
AN-14277
BC226808
CHEBI:32127
CTK4E2490
D01983
D03MZQ
FT-0653684
GLS2PGI8QG
GT 16-026A
HS-0082
KHNXRSIBRKBJDI-UHFFFAOYSA-N
LS-181811
MolPort-005-943-544
MolPort-039-138-690
Oxirane, (chloromethyl)-, polymer with 2-propen-1-amine hydrochloride
PB 94
Phosblock
prop-2-en-1-amine- 2-(chloromethyl)oxirane hydrochloride(1:1:1)
RenaGel
Renastat
Renestat
s4129
Sevelamer HCl
Sevelamer hydrochloride (JAN/USAN)
Sevelamer hydrochloride [USAN]
SEVELAMERHCL
UNII-GLS2PGI8QG

US Patents and Regulatory Information for sevelamer hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Genzyme RENAGEL sevelamer hydrochloride TABLET;ORAL 021179-001 Jul 12, 2000 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Genzyme RENAGEL sevelamer hydrochloride CAPSULE;ORAL 020926-001 Oct 30, 1998 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Genzyme RENAGEL sevelamer hydrochloride TABLET;ORAL 021179-002 Jul 12, 2000 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for sevelamer hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Genzyme RENAGEL sevelamer hydrochloride TABLET;ORAL 021179-002 Jul 12, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Genzyme RENAGEL sevelamer hydrochloride TABLET;ORAL 021179-001 Jul 12, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Genzyme RENAGEL sevelamer hydrochloride TABLET;ORAL 021179-002 Jul 12, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Genzyme RENAGEL sevelamer hydrochloride CAPSULE;ORAL 020926-001 Oct 30, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Genzyme RENAGEL sevelamer hydrochloride TABLET;ORAL 021179-001 Jul 12, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Genzyme RENAGEL sevelamer hydrochloride TABLET;ORAL 021179-002 Jul 12, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Genzyme RENAGEL sevelamer hydrochloride TABLET;ORAL 021179-001 Jul 12, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for sevelamer hydrochloride

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
/2009 Austria ➤ Try a Free Trial PRODUCT NAME: SEVELAMERCARBONAT; REGISTRATION NO/DATE: EU/1/09/521/001- EU/1/09/521/007 20090610
C0011 France ➤ Try a Free Trial PRODUCT NAME: SEVELAMER; REGISTRATION NO/DATE: EU/1/99/123/001 20000128
2002 Austria ➤ Try a Free Trial PRODUCT NAME: SEVELAMER SOWIE DESSEN PHARMAZEUTISCH VERTRAEGLICHEN SALZE; REGISTRATION NO/DATE: EU/1/99/123/001 - EU/1/99/123/004 20000128
00428 Netherlands ➤ Try a Free Trial PRODUCT NAME: SEVELAMER CARBONAAT OF BICARBONAAT; REGISTRATION NO/DATE: EU/1/09/521/001-007 20090610
00080 Netherlands ➤ Try a Free Trial PRODUCT NAME: SEVELAMER, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AAN- VAARDBAAR ZOUT, IN HET BIJZONDER SEVELAMER HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/99/123/001-00420000128 20000128
0716606/01 Switzerland ➤ Try a Free Trial PRODUCT NAME: SEVELAMER; REGISTRATION NUMBER/DATE: SWISSMEDIC 56297 10.02.2004
C/GB02/011 United Kingdom ➤ Try a Free Trial PRODUCT NAME: SEVELAMER; REGISTERED: UK EU/1/99/120/001-004 20000202
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Merck
McKesson
Argus Health
Federal Trade Commission
Baxter
Mallinckrodt
QuintilesIMS
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.